uniQure N.V. (QURE)
Pre-market:
| Previous close | 4.89 |
| Open | 4.90 |
| Bid | 5.03 x 100 |
| Ask | 5.07 x 300 |
| Day's range | 4.83 - 5.19 |
| 52-week range | 4.25 - 22.41 |
| Volume | |
| Avg. volume | 917,732 |
| Market cap | 245.856M |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.47 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.00 |
Simply Wall St.uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
uniQure ( NASDAQ:QURE ) First Quarter 2024 Results Key Financial Results Revenue: US$8.49m (up 59% from 1Q 2023). Net...
GlobeNewswireuniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
~ On track to initiate FDA interaction regarding AMT-130 in second quarter of 2024 and provide a clinical update from the Phase I/II trials in mid-2024 ~ ~ Clinical trial initiation for Fabry disease on track to begin in second quarter of 2024, followed by refractory mesial temporal lobe epilepsy and SOD1-ALS in third quarter of 2024 ~ ~ Comprehensive review of operations and options to reduce expenses underway and expected to be completed in mid-2024 ~ LEXINGTON, Mass. and AMSTERDAM, May 07, 20
Insider Monkey13 Best Biotech Stocks To Buy Under $20
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
